Cambrex, a global CDMO, has expanded its stability storage business, Q1 Scientific by opening up a novel facility in Durham North Carolina.
The site will be co-located next to the Cambrex analytical facility, and will open before the end of 2024, according to the company.
The building will feature advanced storage capabilities — including environmental control — for the pharmaceutical, medical device and life sciences industries.
It will offer 7 ICH stability chambers covering a range of conditions, including:
- 2-8 °C
- 25 °C/40%RH
- 25 °C/60%RH
- 30 °C/65%RH
- 40 °C/75%RH
- -20 °C
- Ultra low -70 to -80 °C
During phase two expansions, which will be carried out within the next two years, the facility’s capacity will be increased to 20 chambers.
The location of the site will also allow US customers to receive deliveries on the same or next day.
CEO at Cambrex, Tom Loewald, stated: “We are thrilled to expand Q1 Scientific’s reach into Durham, North Carolina, enhancing our ability to serve pharmaceutical companies across North America. This investment not only broadens our footprint but also leverages Q1 Scientific’s extensive expertise in the stability storage business.”
Stephen Delaney, Managing Director of Q1 Scientific, added: “Operating three sites globally will be a significant benefit to our customers, who can now expect faster turnaround times for the return of samples and greater temperature-controlled transport options across the US and Europe.”
